Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Gliosarcoma × sapanisertib × Clear all

Sponsor

Conditions

Breast Neoplasms 3 Ovarian Neoplasms 2 Advanced Nonhematologic Malignancies 2 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Thyroid Neoplasms 1 Thyroid Carcinoma, Anaplastic 1 Somatostatinoma 1 Recurrent Lung Squamous Cell Carcinoma 1 Recurrence 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Non-hematologic Malignancy 1 Neoplasm Metastasis 1 Metastatic Castration-Resistant Prostate Cancer 1 Lymphoma 1 Lung Neoplasms 1 Liver Neoplasms 1 Hematologic Neoplasms 1 Glioblastoma 1 Fibrolamellar hepatocellular carcinoma 1 Fallopian Tube Neoplasms 1 Endometrial Neoplasms 1 Carcinoma, Transitional Cell 1 Carcinoma, Renal Cell 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Merkel Cell 1 Carcinoma, Hepatocellular 1 Burkitt Lymphoma 1 Advanced Solid Tumors 1

Interventions

Temozolomide 48 Bevacizumab 31 Radiotherapy 24 Radiation 11 Erlotinib Hydrochloride 11 Radiotherapy, Intensity-Modulated 7 Radiotherapy, Conformal 7 Irinotecan 6 Vorinostat 5 Immunoglobulin G 4 Disulfides 4 Carmustine 4 plerixafor 3 carmustine, poliferprosan 20 drug combination 3 Sorafenib 3 Sirolimus 3 Radiosurgery 3 Magnetic Resonance Spectroscopy 3 Everolimus 3 Dasatinib 3 Bortezomib 3 veliparib 2 vandetanib 2 temsirolimus 2 tandutinib 2 sargramostim 2 pazopanib 2 ferric pyrophosphate 2 cediranib 2 Topotecan 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡